发明名称 BAFF, RELATED BLOCKING AGENTS AND THEIR USE IN STIMULATION AND INHIBITION OF B-CELLS AND IMMUNOGLOBULINS IN IMMUNE RESPONSES
摘要 <p>PROBLEM TO BE SOLVED: To identify and characterize additional molecules which are members of the TNF (Tumor Necrosis Factor) family thereby providing additional means of controlling disorders and manipulating the immune system.SOLUTION: According to the invention, there is provided a use of a soluble BAFF (B cell-activating factor belonging to the TNF family) ligand or an active fragment thereof for preparing a pharmaceutical composition for the treatment of immunosuppressive disorders. There is also provided a use of a soluble BAFF ligand or an active fragment thereof for preparing a pharmaceutical composition for the treatment of the immunosuppressive disorders by stimulating B-cell proliferation in a patient. A use of a soluble BAFF ligand or an active fragment thereof for preparing a pharmaceutical composition for the treatment of the immunosuppressive disorders by stimulating the production of immunoglobulin in a patient is further provided.</p>
申请公布号 JP2014141527(A) 申请公布日期 2014.08.07
申请号 JP20140090152 申请日期 2014.04.24
申请人 BIOGEN IDEC MA INC;TOPOTARGET SWITZERLAND SA 发明人 BROWNING JEFFREY;AMBROSE CHRISTINE;MACKAY FABIENNE;TSCHOPP JUERG;SCHNEIDER PASCAL
分类号 A61K38/00;C12N15/09;A01K67/027;A61K31/44;A61K38/17;A61K38/19;A61K39/395;A61K45/00;A61K48/00;A61P7/00;A61P9/00;A61P9/12;A61P13/12;A61P29/00;A61P31/18;A61P35/00;A61P37/02;A61P37/04;A61P37/06;A61P43/00;C07C233/44;C07C271/22;C07D213/73;C07D401/04;C07D405/12;C07K14/52;C07K14/525;C07K14/705;C07K16/28;C12N5/0781;C12N5/10;C12N15/02;C12N15/85;C12P21/08 主分类号 A61K38/00
代理机构 代理人
主权项
地址